[refractory immune thrombopenic purpura, pregnancy and rituximab].
Illias
I
Tazi
Hatim
H
Nafil
Lahoucine
L
Mahmal
D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D008251:Macaca; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011696:Purpura, Thrombocytopenic / Q000150:complications / Q000188:drug therapy*; D012196:Review Literature as Topic; D000069283:Rituximab; D017211:Treatment Failure
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab